James Ermilio is an associate in the firm’s Corporate Practice Group and represents clients in a broad range of corporate transactions. Mr. Ermilio’s practice includes software and technology licensing agreements, content distribution and media rights agreements, and mergers and acquisitions.
Public-health researchers, officials and medical professionals rely on data to track outbreaks, advance research, and evaluate prospective treatments. One critical source of patient data comes from electronic health records (EHRs). EHR data in the U.S. has traditionally been siloed within hospital IT systems, but the federal government and key healthcare stakeholders have recently ramped up … Continue Reading
On May 28, the White House Office of Science and Technology Policy (OSTP) hosted a meeting of the G7 Science & Technology (S&T) Ministers to collaborate on COVID-19 response and recovery. The G7 S&T Ministers emerged from the meeting with a declaration, in which they expressed their intent to: Enhance cooperation on shared COVID-19 research … Continue Reading
Artificial Intelligence (AI) has played an important role in battling COVID-19 since the initial outbreak: HealthMap – an AI tool from Boston Children’s Hospital that scans news reports, social media, and other data for signs of disease outbreaks – first sounded the international alarm after picking up reports of an emerging virus in Wuhan, China. … Continue Reading